Bright Minds Biosciences Inc. (DRUG) stock
DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
$20.76+0.25 (+1.22%)
Close on Nov 18, 2026Market cap $158.52MP/E –Yield –
Bright Minds Biosciences total assets
Total assets on the balance sheet at the end of each period.
Bright Minds Biosciences's total assets was C$84.42M at Sep 30, 2025. For fiscal 2025 it was C$84.42M, up 1282.9% from the year before. The highest annual figure on record is C$84.42M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | C$84.42M | +1282.9% |
| FY2024 | Sep 30, 2024 | C$6.10M | -11.3% |
| FY2023 | Sep 30, 2023 | C$6.88M | -43.1% |
| FY2022 | Sep 30, 2022 | C$12.09M | -39.7% |
| FY2021 | Sep 30, 2021 | C$20.04M | +2176.8% |
| FY2020 | Sep 30, 2020 | C$880.22K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | C$84.42M | +321.3% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | C$6.10M | +593.5% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | C$6.88M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | C$12.09M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | C$20.04M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | C$880.22K | – |
See a number that looks wrong?